49 results on '"Scharl, M."'
Search Results
2. P627 Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naïve patients with Crohn’s disease by disease location: Results from the EVOLVE Expansion study
3. P746 Identification of Altered Microbial Genera at Baseline in Adalimumab Clinical Remitters and an Absence of Change in Total Microbial Composition Post Induction Treatment in the SERENE UC Study
4. P636 Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naïve patients with Crohn’s disease: Results from the EVOLVE Expansion study
5. P525 A prospective interventional study to evaluate the effect of hypoxia on healthy volunteers and patients with inflammatory bowel disease: The altitude IBD study
6. DOP51 Loss of PTPN23 in the intestinal epithelium results in epithelial hyperproliferation and lethal diarrhea in a microbiota dependent manner
7. P414 Stoma in patiens with IBD: friend or foe? -\tEffect of stoma on course of disease, psychological well-being and working capacity
8. P025 Identification and validation of predictors for tofacitinib through supervised and unbiased approaches in Inflammatory Bowel Disease
9. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease
10. Stromal Cells in the Pathogenesis of Inflammatory Bowel Disease
11. P659 The impact of total colectomy on the course of extraintestinal manifestations in Swiss IBD cohort study patients
12. P825 The impact of a SNP-dose–response effect on course of inflammatory bowel disease: a numerical analysis of SNP distribution within the Swiss IBD Cohort Study
13. P238 Natural history of perianal fistulizing Crohn’s disease in the Swiss IBD cohort
14. P033 Combination of vedolizumab with tacrolimus is more efficient in reducing intestinal inflammation than vedolizumab alone in the DSS-induced acute colitis mouse model
15. DOP34 Transplantation of human intestine into the mouse: A novel platform for study of inflammatory enterocutaneous fistulas
16. DOP53 PTPN2 and TiO2 in the pathogenesis of inflammatory bowel disease
17. DOP87 SUCNR1 a novel key protagonist in fistula development
18. The Oxysterol Synthesising Enzyme CH25H Contributes to the Development of Intestinal Fibrosis
19. P794 Fatigue in inflammatory bowel disease
20. P604 Biologics with or without a combination with 5-ASA in ulcerative colitis: frequency of usage and effect on the course of disease in the Swiss IBD-Cohort study
21. DOP14 TiO2 nanoparticles abrogate the protective effect of the autoimmunity-associated PTPN22R619W variant during acute DSS colitis
22. DOP02 Supplementation with butyrate producing bacteria reduces tumour load in a mouse model of colitis-associated cancer
23. P006 Loss of protein tyrosine phosphatase non-receptor type 23 (PTPN23) in intestinal epithelial cells induces inflammation and epithelial hyperproliferation
24. DOP19 Spermidine treatment ameliorates experimental colitis in vivo
25. OP06 Gut–brain axis revisited: Shedding light on the mucosa-associated microbial composition in IBD patients with psychological distress, anxiety, and depression
26. P046 Iron mobilisation into the intestinal epithelium prevents hypoxia-associated autophagy and reduces inflammation through the inhibition of NF-κB
27. P052 Heat shock protein GP96 is essential for maintaining intestinal epithelial architecture by supporting its self-renewal capacity
28. P046 Presence of an autoimmunity-associated variant in PTPN22 promotes chronic colitis in a microbiota dependent manner
29. P513 Early initiation of anti-TNF is associated with favourable long-term outcome in Crohn’s disease: Ten-year follow-up data from the Swiss IBD cohort study
30. P087 A novel OGR1 (GPR68) inhibitor attenuates inflammation in a murine model of Acute Colitis
31. DOP013 An IBD-associated variant in PTPN2 promotes inflammatory responses but enhances the anti-inflammatory effect of spermidine
32. P855 Vegetarian and gluten-free diet in patients with IBD—associated with a different microbiota compared with omnivore IBD patients
33. P066 Pharmacologic inhibition of integrin αvβ6 causes tumour shrinkage in colitis associated mouse colon tumours
34. P007 Activation of pH-sensing receptor OGR1 (GPR68) induces ER stress and autophagy in an intestinal epithelial cell model
35. P068 Loss of PTPN22 abrogates the beneficial effect of faecal microbiota transfer
36. OP030 Loss of PTPN2 in dendritic cells promotes T-cell activation and expression of co-stimulatory molecules
37. DOP079 Heat-shock protein GP96 is essential for self-renewal of the intestinal epithelial barrier
38. P712 Risk factors for the development of fistulae and stenoses in Crohn's disease patients in the Swiss IBD cohort
39. DOP089 PTPN2 controls intestinal inflammation and promotes colitis-associated tumour formation via control of inflammasome activation and IL-1alpha release
40. P768 Co-housing DSS treated mice with healthy mice results in faster recovery and normalization of the intestinal microbiota
41. P711 Vegetarian or gluten-free diet in patients with IBD – associated with lower psychological well-being and quality of life but no indication of beneficial effects on course of disease
42. DOP056 Pathophysiology of perianal fistulising disease
43. P390 Patient perceptions on the impact of coffee consumption in inflammatory bowel disease: friend or foe?
44. P019 T cell specific loss of PTPN2 results in aggravated colitis and pronounced intestinal dysbiosis as observed in Crohn's disease patients
45. P081 ER stress leads to epithelial to mesenchymal transition (EMT) in intestinal epithelial cells in a JNK- and Src-dependent manner
46. DOP016 Smoking cessation alters intestinal microbiota – further insights from quantitative investigations on human faecal samples using FISH and qPCR
47. P040 Protein tyrosine phosphate non receptor type 22 regulates muramyl-dipeptide induced effects in human monocytes
48. OP20 TNF and MDP induce epithelial-to-mesenchymal transition in human intestinal cells: Implications for the pathogenesis of Crohn's disease-associated fistulae and the use of anti-TNF antibodies
49. P282 Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis an open pilot study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.